rs375165169

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2

The NM_021098.3(CACNA1H):​c.2455G>A​(p.Glu819Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000354 in 1,611,202 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000034 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

1
9
9

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 5.51

Publications

1 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3471261).
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.2455G>A p.Glu819Lys missense_variant Exon 11 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.2455G>A p.Glu819Lys missense_variant Exon 11 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.2455G>A p.Glu819Lys missense_variant Exon 11 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.2455G>A p.Glu819Lys missense_variant Exon 11 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.2455G>A p.Glu819Lys missense_variant Exon 11 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.2455G>A p.Glu819Lys missense_variant Exon 11 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.2455G>A p.Glu819Lys missense_variant Exon 11 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.2416G>A p.Glu806Lys missense_variant Exon 11 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.2455G>A p.Glu819Lys missense_variant Exon 11 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.2416G>A p.Glu806Lys missense_variant Exon 11 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.2455G>A p.Glu819Lys missense_variant Exon 11 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.2455G>A p.Glu819Lys missense_variant Exon 11 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.2455G>A p.Glu819Lys missense_variant Exon 11 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.2455G>A p.Glu819Lys missense_variant Exon 11 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.2455G>A p.Glu819Lys missense_variant Exon 11 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.2455G>A non_coding_transcript_exon_variant Exon 11 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.2455G>A non_coding_transcript_exon_variant Exon 11 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.2455G>A non_coding_transcript_exon_variant Exon 11 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*368G>A non_coding_transcript_exon_variant Exon 11 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*1902G>A non_coding_transcript_exon_variant Exon 10 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.2455G>A non_coding_transcript_exon_variant Exon 11 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.2455G>A non_coding_transcript_exon_variant Exon 11 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.2455G>A non_coding_transcript_exon_variant Exon 11 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.2455G>A non_coding_transcript_exon_variant Exon 11 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.2455G>A non_coding_transcript_exon_variant Exon 11 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.2455G>A non_coding_transcript_exon_variant Exon 11 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.2455G>A non_coding_transcript_exon_variant Exon 11 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.2455G>A non_coding_transcript_exon_variant Exon 11 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.2455G>A non_coding_transcript_exon_variant Exon 11 of 35 ENSP00000518777.1
CACNA1HENST00000640028.1 linkn.*368G>A 3_prime_UTR_variant Exon 11 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000711442.1 linkn.*1902G>A 3_prime_UTR_variant Exon 10 of 34 ENSP00000518758.1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152170
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000163
AC:
4
AN:
245826
AF XY:
0.0000224
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000582
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000180
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000343
AC:
50
AN:
1458914
Hom.:
0
Cov.:
32
AF XY:
0.0000344
AC XY:
25
AN XY:
725770
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33454
American (AMR)
AF:
0.0000448
AC:
2
AN:
44624
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26092
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39674
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86154
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51332
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.0000423
AC:
47
AN:
1111508
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152288
Hom.:
0
Cov.:
33
AF XY:
0.0000537
AC XY:
4
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41548
American (AMR)
AF:
0.000261
AC:
4
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68012
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000416
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000119
AC:
1
ExAC
AF:
0.0000331
AC:
4
EpiCase
AF:
0.00
EpiControl
AF:
0.0000594

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Mar 22, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Uncertain:1
Jun 19, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 819 of the CACNA1H protein (p.Glu819Lys). This variant is present in population databases (rs375165169, gnomAD 0.006%). This missense change has been observed in individual(s) with clinical features of trigeminal neuralgia (PMID: 33083721). ClinVar contains an entry for this variant (Variation ID: 377295). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CACNA1H protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects CACNA1H function (PMID: 36397158). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

not provided Uncertain:1
Jan 31, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.0042
T
BayesDel_noAF
Uncertain
-0.070
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.74
D;.;.;.
Eigen
Benign
-0.17
Eigen_PC
Benign
-0.19
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.96
D;D;D;.
M_CAP
Pathogenic
0.29
D
MetaRNN
Benign
0.35
T;T;T;T
MetaSVM
Uncertain
0.71
D
MutationAssessor
Benign
1.1
L;.;L;L
PhyloP100
5.5
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-3.3
D;.;D;D
REVEL
Uncertain
0.33
Sift
Benign
0.040
D;.;D;D
Sift4G
Uncertain
0.043
D;.;D;D
Polyphen
0.083
B;.;P;P
Vest4
0.53
MVP
0.75
ClinPred
0.68
D
GERP RS
3.9
Varity_R
0.44
gMVP
0.53
Mutation Taster
=79/21
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375165169; hg19: chr16-1255117; COSMIC: COSV62006290; COSMIC: COSV62006290; API